DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of
rhodopsin: A G protein–coupled receptor. Science, 2000,
289:739–745.
Park PS-H, Lodowski DT, Palczewski K. Activation of G-proteincoupled
receptors: Beyond two state models and tertiary conformational
changes. Annu Rev Pharmacol Toxicol 2008,
48:107–141.
Philipp M, Hein L. Adrenergic receptor knockout mice: Distinct
functions of 9 receptor subtypes. Pharmacol Ther, 2004,
101:65–74.
Richman JG, Regan JW. α 2
-Adrenergic receptors increase cell
migration and decrease F-actin labeling in rat aortic smooth
muscle cells. Am J Physiol, 1998, 274:C654–C662.
Robertson D, Haile V, Perry SE, et al. Dopamine β-hydroxylase
deficiency: A genetic disorder of cardiovascular regulation.
Hypertension, 1991, 18:1–8.
Robidoux J, Martin TL, Collins S. β-Adrenergic receptors and
regulation of energy expenditure: A family affair. Annu Rev
Pharmacol Toxicol, 2004, 44:297–323.
Rubanyi GM, Polokoff MA. Endothelins: Molecular biology,
biochemistry, pharmacology, physiology, and pathophysiology.
Pharmacol Rev, 1994, 46:325–415.
Sanes JR, Lichtman JW. Development of the vertebrate neuromuscular
junction. Annu Rev Neurosci, 1999, 22:389–442.
Saper CB. Pain as a visceral sensation. Prog Brain Res, 2000,
122:237–243.
Saper CB. The central autonomic nervous system: Conscious
visceral perception and autonomic pattern generation. Annu
Rev Neurosci, 2002, 25:433–469.
Schuldiner S. A molecular glimpse of vesicular monoamine
transporters. J Neurochem, 1994, 62:2067–2078.
Silinsky EM, von Kügelgen I, Smith A, Westfall DP. Functions
of extracellular nucleotides in peripheral and central neuronal
tissues. In, The P 2
Nucleotide Receptors. (Turner JT, Weisman
GA, Fedan JS, eds.) Humana Press, Totowa, NJ, 1998, pp.
259–290.
Silman I, Sussman JL. Acetylcholinesterase: “classical and nonclassical”
functions and pharmacology. Curr Opin Pharmacol,
2005, 5:293–302.
Sneddon P, Westfall DP. Pharmacological evidence that
adenosine trisphosphate and noradrenaline are co-transmitters
in the guinea-pig vas deferens. J Physiol, 1984, 347:561–580.
Sneddon P, Westfall TD, Todorov LD, et al. Modulation of purinergic
neurotransmission. Prog Brain Res, 1999, 120:11–20.
Sokolovsky M. Endothelin receptor subtypes and their role in
transmembrane signaling mechanisms. Pharmacol Ther, 1995,
68:435–471.
Strader CD, Fong TM, Tota MR, et al. Structure and function of
G protein–coupled receptors. Annu Rev Biochem, 1994,
63:101–132.
Südhof TC. The synaptic vesicle cycle. Annu Rev Neurosci,
2004, 27:509–547.
Tan CM, Limbird LE. The α 2
-adrenergic receptors: Lessons
from knockouts. Clifton, NJ Humana, 2005, pp. 241–266.
Tanoue A, Koshimizu TA, Tsujimoto G. Transgenic studies of
α 1
-adrenergic receptor subtype function. Life Sci, 2002a,
71:2207–2215.
Tanoue A, Nasa Y, Koshimizu T, et al. The α 1D
-adrenergic receptor
directly regulates arterial blood pressure via vasoconstriction.
J Clin Invest, 2002b, 109:765–775.
Taupenot L, Harper KL, O’Connor DT. The chromogranin–
secretogranin family. N Engl J Med, 2003, 348:1134–1149.
Taylor P, Luo ZD, Camp S. The genes encoding the
cholinesterases: Structure, evolutionary relationships and regulation
of their expression. In, Cholinesterase and
Cholinesterase Inhibitors. (Giacobini E, ed.) London, Martin
Dunitz, 2000, pp. 63–80.
Toda N, Okamura J. The pharmacology of nitric oxide in the
peripheral nervous system of blood vessels. Pharmacol Rev,
2003, 55:271–324.
Todorov LD, Mihaylova-Todorova S, Craviso GL, et al.
Evidence for the differential release of the cotransmitters ATP
and noradrenaline from sympathetic nerves of the guinea-pig
vas deferens. J Physiol, 1996, 496:731–748.
Tsien RW, Lipscombe D, Madison DV, et al. Multiple types of
neuronal calcium channels and their selective modulation.
Trends Neurosci, 1988, 11:431–438.
Vanhoutte PM. Endothelium-dependent responses in congestive
heart failure. J Mol Cell Cardiol, 1996, 28:2233–2240.
van Koppen CJ, Kaiser B. Regulation of muscarinic acetylcholine
signaling. Pharmacol Ther, 2003, 98:197–220.
Varoqui H, Erickson JD. Vesicular neurotransmitter transporters:
Potential sites for the regulation of synaptic function. Mol
Neurobiol, 1997, 15:165–191.
Violin JD, Lefkowitz RJ, β-arrestin-biased ligands at seventransmembrane
receptors. Trends Pharmacol Sci, 2007,
28:416–422.
Viskupic E, Kvetnansky R, Sabban EL, et al. Increase in rat
adrenal phenylethanolamine N-methyltransferase mRNA
level caused by immobilization stress depends on intact
pituitary-adrenocortical axis. J Neurochem, 1994, 63:
808–814.
Volz HP, Gleiter CH. Monoamine oxidase inhibitors: A perspective
on their use in the elderly. Drugs Aging, 1998, 13:341–355.
von Euler. U.S. Synthesis, uptake and storage of catecholamine
in adrenergic nerves: The effects of drugs. In, Catecholamine:
Handbuch der Experimentellen Pharmakologie, vol. 33.
(Blaschko H, Muscholl E, eds.) Springer-Verlag, Berlin, 1972,
pp. 186–230.
Walden PD, Durkin MM, Lepor H, et al. Localization of mRNA
and receptor binding sites for the α 1A
-adrenoceptor subtype in
the rat, monkey and human urinary bladder and prostate. J
Urol, 1997, 157:1032–1038.
Wang Z, Shi H, Wang H. Functional M 3
muscarinic acetylcholine
receptors in mammalian hearts. Br J Pharmacol, 2004,
142:395–408.
Ward SE, Beckett EAH, Wang XY, et al. Interstitial cells of cajal
mediate cholinergic neurotransmission from enteric motor
neurons J Neurosci, 2000, 20:1393–1403.
Wess J. Muscarinic acetylcholine receptor knockout mice: Novel
phenotypes and clinical implication. Annu Rev Pharmacol
Toxicol, 2004, 44:423–450.
Wess J, Eglen RM, Gantam D. Muscarinic acetylcholine receptors:
mutant mice provide new insights for drug development.
Nature Rev/Drug Discov, 2007, 6:721–733.
Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the
non-neuronal cholinergic system in humans. Br J Pharmacol
2008, 154:1558–1571.
Westfall DP, Dalziel HH, Forsyth KM. ATP as neurotransmitter,
cotransmitter and neuromodulator. In, Adenosine and Adenine
217
CHAPTER 8
NEUROTRANSMISSION: THE AUTONOMIC AND SOMATIC MOTOR NERVOUS SYSTEMS